- Zenflow secures $52M Series D financing to support commercialization of its Spring System
Zenflow secures $52M Series D financing to support commercialization of its Spring System
- InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
InkSpace Imaging earns FDA clearance for flexible MRI coil on Philips 1.5T systems
- Purple AI closes Series A, doubles valuation as it targets US stroke AI market
Purple AI closes Series A, doubles valuation as it targets US stroke AI market
- CraniUS closes $20M financing to support blood-brain barrier tech for drug delivery
CraniUS Therapeutics announced that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass. NeuroPass is a fully implantable, skull-embedded platform. The Baltimore-based company designed it to bypass the blood-brain barrier (BBB). It could enable targeted dru
- Bluedrop Medical picks up $1.2M for diabetic foot ulcer detection tech
The Irish Independent reports that Bluedrop Medical secured approximately $1.2М in funding from Enterprise Ireland. Galway-based Bluedrop develops technology aimed at reducing the rate of preventable amputations for people living with diabetes. It develops of an internet of things (IOT)-enabled devi
- Boston Scientific invests $1.5B in TAVR developer MiRus
Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus. Marlborough, Massachusetts–based Boston Scientific now has an equity stake in MiRus worth approximately 34%. The deal also includes an exclusive option to acquire MiRus’ Siegel
- Xeltis gains EU CE mark on positive trial data for vascular access graft
Xeltis has gained a European CE mark for aXess, with 12-month pivotal data of the vascular access graft for haemodialysis demonstrating strong and higher secondary patency versus conventional arteriovenous grafts (AVGs). Xeltis’s aXess is a bioabsorbable graft for haemodialysis that is injected unde
- EmStop initiates IDE study of novel embolic protection device
EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS). CAPTURE-2 evaluates the safety and performance of the EPS, an investigational device for cerebral embolic protection designed to capture and remove debris that i
Market Insight
Evidence-Based Deep Dive
Top Picks
Latest MedTech News
CraniUS Therapeutics announced that it raised $20 million in a Series B financing round to accelerate its development of NeuroPass.
NeuroPass is a fully implantable, skull-embedded platform. The Baltimore-based company designed it to bypass the blood-brain barrier (BBB). It could enable targeted drug
The Irish Independent reports that Bluedrop Medical secured approximately $1.2М in funding from Enterprise Ireland.
Galway-based Bluedrop develops technology aimed at reducing the rate of preventable amputations for people living with diabetes. It develops of an internet of things (IOT)-enabled devic
Boston Scientific announced that it invested $1.5 billion in transcatheter aortic valve replacement (TAVR) developer MiRus.
Marlborough, Massachusetts–based Boston Scientific now has an equity stake in MiRus worth approximately 34%. The deal also includes an exclusive option to acquire MiRus’ Siegel
Xeltis has gained a European CE mark for aXess, with 12-month pivotal data of the vascular access graft for haemodialysis demonstrating strong and higher secondary patency versus conventional arteriovenous grafts (AVGs).
Xeltis’s aXess is a bioabsorbable graft for haemodialysis that is injected under
EmStop announced that it kicked off the CAPTURE-2 FDA investigational device exemption (IDE) study of its embolic protection system (EPS).
CAPTURE-2 evaluates the safety and performance of the EPS, an investigational device for cerebral embolic protection designed to capture and remove debris that in